Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 4/20 | 0.66 |
| ▸ | NAAA | Q02083 | 3/20 | 0.56 |
| ▸ | HTR3A | P46098 | 1/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.48 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL425325 | 0.94 | MIF (0.67) | MIFNAAAHTR3ATRPA1CYP2E1 | |
| SCHEMBL11419140 | 0.93 | MIF (0.58) | MIFNAAAHTR3ATRPA1CYP2E1 | |
| SCHEMBL1006435 | 0.92 | NAAA (0.68) | MIFNAAAHTR3ATRPA1CYP2E1 | |
| SCHEMBL4332687 | 0.92 | NAAA (0.68) | MIFNAAAHTR3ATRPA1CYP2E1 | |
| SCHEMBL380832 | 0.92 | NAAA (0.68) | MIFNAAAHTR3ATRPA1CYP2E1 | |
| SCHEMBL11240241 | 0.92 | NAAA (0.68) | MIFNAAAHTR3ATRPA1CYP2E1 | |
| SCHEMBL11419613 | 0.91 | MIF (0.56) | MIFNAAAHTR3ATRPA1CYP2E1 | |
| SCHEMBL11411086 | 0.91 | MIF (0.56) | MIFNAAAHTR3ATRPA1CYP2E1 | |
| SCHEMBL11413060 | 0.91 | MIF (0.56) | MIFNAAAHTR3ATRPA1CYP2E1 | |
| SCHEMBL330828 | 0.89 | MIF (0.50) | MIFNAAAHTR3ATRPA1CYP2E1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119285502-A | Free radical self-release antifouling agent containing oxime urethane group and preparation method and application thereof | 哈尔滨工程大学 | 2025-01-10 | — | — | CN | claimed |
| CN-118667362-A | High-compatibility modified acetylene black, preparation method and application thereof | 扬州腾飞电缆电器材料有限公司 | 2024-09-20 | — | — | CN | claimed |
| EP-3681476-B1 | TRANSDERMAL FORMULATIONS | TYME INC (US) | 2022-09-14 | — | — | EP | claimed |
| CN-114716772-A | Microcellular foamed EPDM and preparation method thereof | 台州学院 | 2022-07-08 | — | — | CN | claimed |
| CN-114561122-A | Ink set and recording method | 精工爱普生株式会社 | 2022-05-31 | — | — | CN | claimed |
| US-20200405680-A1 | TRANSDERMAL FORMULATIONS | TYME, INC. (US) | 2020-12-31 | — | — | US | claimed |
| EP-3681476-A1 | TRANSDERMAL FORMULATIONS | Tyme, Inc. (US) | 2020-07-22 | — | — | EP | claimed |
| CN-111328278-A | Transdermal preparation | 迪美公司 | 2020-06-23 | — | — | CN | claimed |
| WO-2019055747-A1 | TRANSDERMAL FORMULATIONS | TYME, INC. (US) | 2019-03-21 | — | — | WO | claimed |
| CN-107428897-A | Iso (thio) cyanate composition and resin composition for optical member using the same | 豪雅镜片泰国有限公司 | 2017-12-01 | — | — | CN | claimed |
| EP-4747247-A1 | NOVEL FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | Apogee Pharmaceuticals, Inc. (CA) | 2026-05-27 | — | — | EP | disclosed |
| EP-4713378-A1 | ESTERIFIED ETHANOLAMINES FOR PREPARING ISOCYANURATE POLYMERS | Covestro Deutschland AG (DE) | 2026-03-25 | — | — | EP | disclosed |
| US-20250281424-A1 | SMALL MOLECULE ANTAGONISTS OF PF4 | ZHOU YUHANG (US) | 2025-09-11 | — | — | US | disclosed |
| US-12410137-B2 | Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof | APOGEE PHARMACEUTICALS, INC. (CA) | 2025-09-09 | — | — | US | disclosed |
| US-20250129027-A1 | FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | APOGEE PHARMACEUTICALS, INC. (CA) | 2025-04-24 | — | — | US | disclosed |
| US-4657893-A | ANTIINFLAMMATORY AGENTS | SYNTEX (U.S.A.) INC. (US) | 1987-04-14 | — | — | US | disclosed |
| EP-0147211-A2 | 4H-3,1-benzoxazin-4-ones and related compounds, pharmaceutical compositions containing them, and processes for their preparation | SYNTEX (U.S.A.) INC. (US) | 1985-07-03 | — | — | EP | disclosed |
| US-4232951-A | DISPLAY DEVICE FOR MEMORY OR TEMPERATURE FUNCTIONS | ALLIED CHEMICAL CORPORATION (US) | 1980-11-11 | — | — | US | disclosed |
| US-4200575-A | 7[(2-Thiazolyl)-2-(oxoimino)acetamido]cephalosporin derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1980-04-29 | — | — | US | disclosed |
| US-4094978-A | 3-PROPENYL DERIVATIVES OF CEPHALOSPORIN, COMPOSITIONS AND THEIR USE | SYNTEX (U.S.A.) INC. (US) | 1978-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129027-A1 | FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | FAAH, FAAH2, MGLL | MIF 1583/4885NAAA 19/4885HTR3A 703/4885 |
| US-20250281424-A1 | SMALL MOLECULE ANTAGONISTS OF PF4 | PF4, F12, F2 | MIF 3938/4885NAAA 3605/4885HTR3A 2311/4885 |
| US-12410137-B2 | Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof | FAAH, FAAH2, MGLL | MIF 1583/4885NAAA 19/4885HTR3A 703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.